Background The hepatitis C virus (HCV) is a major public health problem and a leading
cause of chronic liver disease. In the United States, the Centers for Disease Control and …

Hepatitis C virus (HCV) accounts for approximately 20% of cases of acute hepatitis, 70% of
chronic hepatitis, and 30% of end-stage liver disease in the United States. The acute …

Background: Serum alanine aminotransferase (ALT) activity, the variable most commonly
measured to assess hepatic disease, fails to identify many patients with hepatic injury …

A retrospective study was performed to (1) characterize the clinical and histologic features of
those with nonalcoholic fatty liver disease (NAFLD) and normal alanine aminotransferase …

Objective: A liver biopsy is necessary to grade and stage chronic hepatitis C virus (HCV)
infection. In a previous study of patients with nonalcoholic liver disease, an aspartate …

Erlich is credited with the first liver aspiration in 1883 and subsequently the first
percutaneous liver biopsy for diagnostic purposes was reported in 1923. 1 The technique …

Chronic viral hepatitis is the principal cause of chronic liver disease, cirrhosis, and
hepatocellular carcinoma in the world and now ranks as the chief reason for liver …

BACKGROUND & AIMS: Nonalcoholic fatty liver disease (NAFLD) is the hepatic
manifestation of obesity and metabolic syndrome (MetS). Alanine aminotransferase (ALT) …

In this review the current overall knowledge on hepatitis A, B, C, D, and E will be discussed.
These diseases are all characterized by liver inflammation but have significant differences in …

Because of the nucleotide sequence diversity of different isolates of hepatitis C virus, it has
become important to clarify whether distinct genotypes of hepatitis C virus vary with respect …